692
Participants
Start Date
September 30, 2005
Primary Completion Date
June 30, 2007
Study Completion Date
May 31, 2012
LPV/RTV
400/100 mg twice daily or 800/200 mg daily depending on the country for max. 192 weeks
TMC-114/RTV
two 400 mg tablets of TMC114 + one 100 mg capsule of RTV daily for max. 192 weeks
Phoenix
Beverly Hills
Long Beach
Los Angeles
Sacramento
San Francisco
Washington D.C.
Fort Lauderdale
Jacksonville
Miami
Miami Beach
Orlando
Safety Harbor
Tampa
Vero Beach
Baltimore
Boston
Las Vegas
Brooklyn
Chapel Hill
Winston-Salem
Philadelphia
Columbia
Houston
Buenos Aires
Mar del Plata
Neuquén
Brisbane
Darlinghurst
Surry Hills
Westmead
Vienna
Brussels
Ghent
Leuven
Vancouver
Ottawa
Toronto
Montreal
Providencia
Santiago
Costa Rica
San José
Aalborg
Copenhagen Ø
Hvidovre
Bobigny
Lyon
Nice
Orléans
Paris
Berlin
Cologne
Erlangen
Freiburg im Breisgau
Hamburg
Mannheim
Munich
München
Athens
Guatemala City
Sungai Buloh
Del Tlalpan
Guadalajara
Mex Ctity
Mexico City
Panama City
San Juan
Kazan'
Krasnodar
Moscow
Saint Petersburg
Smolensk
Volgograd
Voronezh
Singapore
Cape Town
Dundee
Johannesburg
Pretoria
Barcelona
Zurich
Taipei
Tiachung
Bangkok
Chiang Mai
Khon Kaen
Brighton
London
Tibotec Pharmaceuticals, Ireland
INDUSTRY